Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Postsurgical Atrial Fibrillation Increases Heart Attack Risk

By HospiMedica International staff writers
Posted on 03 Jun 2015
A new study suggests that postoperative atrial fibrillation (POAF) can significantly increase the risk of heart attack or stroke during the year after surgery.

Researchers at Loyola University Medical Center (Maywood, IL, USA) examined the Healthcare Cost and Utilization Project (HCUP) inpatient databases for California and Florida, identifying 4,345 patients who underwent radical cystectomy between 2007 and 2010, of whom 210 (4.8%) developed POAF. More...
After excluding patients with a prior history of atrial fibrillation (AF), coronary artery disease, and/or stroke, the patients were matched for age, race, insurance status, and preexisting comorbidities.

The researchers then assessed the effect of POAF on cardiovascular events over the first year postoperatively. The results showed that among those patients who developed POAF, 24.8% experienced a heart attack or stroke during the first 12 months after surgery. By comparison, less than half (10.9%) of the patients who did not experience POAF experienced a myocardial infarct (MI) or stroke during the first year. The study was published ahead of print on April 3, 2015, in the Journal of Urology.

“Our results demonstrate that patients undergoing radical cystectomy who develop transient postoperative atrial fibrillation are at a significantly increased risk of cardiovascular events within the first postoperative year,” concluded lead author Robert Blackwell, MD, and colleagues. “Physicians should be vigilant in assessing postoperative atrial fibrillation, even when transient, and establish appropriate follow-up, given the increased risk of cardiovascular morbidity.”

POAF following radical cystectomy occurs in 2%–8% of cases, and is also the most frequent complication following cardiovascular surgery. Conventional viewpoints suggest that POAF is less likely to affect the survival of patients when compared with chronic AF, although it does slightly prolong the duration of hospital stay. However, newer reports suggest that POAF is associated with a significantly higher incidence of various complications, including cardiovascular events, renal failure, infection, and cerebral infarction.

Related Links:

Loyola University Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.